Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Role of Lung Ultrasound in Screening for Interstitial Lung Disease in Patients With Rheumatoid Arthritis
A completed clinical trial evaluated lung ultrasound as a screening tool for interstitial lung disease in patients with rheumatoid arthritis…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Assessment of Diaphragmatic Mobility in Dyspneic Patients With Different Types of Interstitial Lung Diseases
This clinical trial update reports the completion of a study assessing diaphragmatic mobility in dyspneic patients across different types of…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: BAL Contribution to Lung Cryo-TBB in ILD [NA]
A completed clinical trial evaluating bronchoalveolar lavage contribution to lung cryo-transbronchial biopsy in interstitial lung disease.
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis [Phase 3]
Phase 3 multinational trial evaluating the efficacy and safety of inhaled treprostinil in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH) [Phase 2]
Phase 2 trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of BAY63-2521 in patients with inters…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: FAPI PET for Lung Fibrosis [EARLY_Phase 1]
An early-phase Phase 1 trial evaluating FAPI PET imaging for interstitial lung disease and pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis [Phase 2]
Phase 2 clinical trial evaluating rituximab for treatment-refractory hypersensitivity pneumonitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19 [Phase 3]
A Phase 3 study evaluating the efficacy and safety of Longidaza for residual lung changes after COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Azithromycin and Oesophageal Function in Respiratory Disease
A completed clinical trial evaluating the effect of azithromycin on esophageal function in individuals with respiratory conditions, includin…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis [Phase 3]
A Phase 3 trial in China tested nintedanib for progressive lung fibrosis, with results posted in May 2025.
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Interstitial Lung Disease Exacerbations Study
Clinical trial update for an interstitial lung disease/exacerbations study sponsored by Royal Devon and Exeter NHS Foundation Trust. The tri…
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: Effect of Pulmonary Telerehabilitation and Telemonitoring for Patients With Chronic Respiratory Diseases [NA]
A clinical trial evaluating pulmonary telerehabilitation and telemonitoring in patients with chronic respiratory diseases has completed. The…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
The real-world INREAL study reports results of nintedanib (Ofev) in patients with chronic fibrosing interstitial lung disease with a progres…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease
Completed clinical trial evaluating a shared decision-making intervention for adults with advanced lung disease.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients [Phase 2]
Phase 2 trial evaluating the safety and tolerability of oral Ixazomib in scleroderma-related lung disease was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Opportunistic Screening for Osteoporotic Vertebral Fractures in Patients With Diffuse Interstitial Lung Disease
This clinical trial update reports on a completed study evaluating opportunistic screening for osteoporotic vertebral fractures in patients …
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults [Phase 1]
Phase 1 trial evaluating multiple-dose Genakumab injections in Chinese healthy adults, with Interstitial Lung Disease listed as the conditio…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease [Phase 2]
A Phase 2 study evaluating the safety and tolerability of Treprostinil Palmitil Inhalation Powder in participants with Pulmonary Hypertensio…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) [NA]
University of Washington completed Trial 2 of a hospital-based program to improve communication about serious illness; results have been pos…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 [Phase 4]
Phase 4 study evaluating nintedanib for slowing lung disease in patients with fibrotic or non-fibrotic interstitial lung disease related to …
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Open-label Study With Bosentan in Interstitial Lung Disease [Phase 2, Phase 3]
Open-label Phase 2/3 study of bosentan in interstitial lung disease and systemic sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Specialist Dietetic Intervention in Malnourished Patients with Fibrotic ILD: a Randomised Controlled Pilot Trial [NA]
A completed randomized controlled pilot trial evaluating a specialist dietetic intervention in malnourished patients with fibrotic interstit…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease [Phase 2]
A Phase 2 study evaluating abatacept for myositis-associated interstitial lung disease has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMF [Phase 3]
Phase 3 clinical trial evaluating a selective JAK inhibitor for interstitial lung disease due to systemic disease and skin tightness in syst…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest [NA]
Completed Johns Hopkins trial evaluating oxygen delivery strategies. The study compares administered oxygen with high-flow ambient air at re…